Literature DB >> 14593529

The impact of factor XIIIa V34L polymorphism on plasma factor XIII activity in the Chinese and Asian Indians from Singapore.

Chew-Kiat Heng1, Suman Lal, Nilmani Saha, Poh-Sim Low, M Ilyas Kamboh.   

Abstract

Factor XIII (FXIII) is a plasma transglutaminase that is essential for normal haemostasis and fibrinolysis. A few polymorphic sites have been identified in the gene, one of them being a point mutation (V34L) in exon 2 of the FXIIIa subunit gene leading to an amino acid change of valine to leucine. We have examined the role of this polymorphism in relation to plasma FXIII activity in a total of 532 healthy individuals belonging to two ethnic groups in Singapore. The frequency of the L34 allele was significantly higher ( P<0.001) among the Asian Indians (0.08) when compared with the Chinese (0.005). No significant difference in frequency of the L34 allele was observed between Asian Indian CAD patients and controls. The mean FXIII levels were significantly higher ( P<0.0005) among the Asian Indians (148.4%+/-35.5) when compared with Chinese (111.2%+/-26.7). The L34 variant was associated with increased FXIII activity among Asian Indian females. This study shows that both racial and genetic components play a significant role in determining plasma FXIII activity. The effect of V34L polymorphism on FXIII activity in the Indian females is independent of the effects of the P564L and E651Q polymorphic sites in the FXIIIa gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593529     DOI: 10.1007/s00439-003-1040-3

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  31 in total

1.  Ethnic heterogeneity of the factor XIII Val34Leu polymorphism.

Authors:  F A Attié-Castro; M A Zago; J Lavinha; J Elion; L Rodriguez-Delfin; J F Guerreiro; R F Franco
Journal:  Thromb Haemost       Date:  2000-10       Impact factor: 5.249

2.  A photometric assay for blood coagulation factor XIII.

Authors:  K Fickenscher; A Aab; W Stüber
Journal:  Thromb Haemost       Date:  1991-05-06       Impact factor: 5.249

3.  Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage.

Authors:  A J Catto; H P Kohler; S Bannan; M Stickland; A Carter; P J Grant
Journal:  Stroke       Date:  1998-04       Impact factor: 7.914

4.  Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation.

Authors:  T A Trumbo; M C Maurer
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

5.  Genetic polymorphisms and coronary artery disease in the south of France.

Authors:  I Canavy; M Henry; P E Morange; L Tiret; O Poirier; A Ebagosti; M Bory; I Juhan-Vague
Journal:  Thromb Haemost       Date:  2000-02       Impact factor: 5.249

6.  Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.

Authors:  M L Schwartz; S V Pizzo; R L Hill; P A McKee
Journal:  J Biol Chem       Date:  1973-02-25       Impact factor: 5.157

7.  Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.

Authors:  W Renner; H Köppel; C Hoffmann; K Schallmoser; O Stanger; H Toplak; T C Wascher; E Pilger
Journal:  Thromb Res       Date:  2000-07-01       Impact factor: 3.944

8.  No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age.

Authors: 
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

9.  Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.

Authors:  Y Sakata; N Aoki
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

10.  The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity.

Authors:  S Kangsadalampai; P G Board
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

View more
  3 in total

1.  Factor XIII gene V34L mutation in the Lebanese population: another unique feature in this community?

Authors:  Rami A R Mahfouz; Amira S Sabbagh; Dina M R Shammaa; Zaher K Otrock; Ghazi S Zaatari; Ali T Taher
Journal:  Mol Biol Rep       Date:  2007-05-22       Impact factor: 2.316

2.  Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey.

Authors:  Serdar Oztuzcu; Sercan Ergun; Mustafa Ulaşlı; Gülper Nacarkahya; Yusuf Ziya Iğci; Mehri Iğci; Recep Bayraktar; Ali Tamer; Ecir Ali Çakmak; Ahmet Arslan
Journal:  Mol Biol Rep       Date:  2014-02-15       Impact factor: 2.316

3.  Factor XIII polymorphism and risk of aneurysmal subarachnoid haemorrhage in a south Indian population.

Authors:  Arati Suvatha; M K Sibin; Dhananjaya I Bhat; K V L Narasingarao; Vikas Vazhayil; G K Chetan
Journal:  BMC Med Genet       Date:  2018-09-05       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.